The Canadian COVID‑19 Funded Research Database

Algonquin College
Ambrose University
Association for Canadian Studies
Athabasca University
Aurora College

B.C. Centre for Disease Control
B.C. Centre for Excellence in HIV/AIDS
B.C. Children's Hospital
B.C. Women's Hospital
Bishop's University
Brandon University
British Columbia Centre on Substance Use
Brock University
Bruyère Research Institute

Dalhousie University
Dawson College
Durham College

École de technologie supérieure
École nationale d'administration publique
École Polytechnique de Montréal
Emily Carr University of Art and Design

Fanshawe College
First Nations Health Authority
Fleming College

Georgian College
Grant MacEwan University

HEC Montréal
Hospital for Sick Children
Humber College
Huron University College

Indigenous Diabetes Health Circle
INRS
Institut de recherches cliniques de Montréal
Institut de tourisme et d'hôtellerie du Québec
Institut national de la recherche scientifique
Institut national de santé publique du Québec
Institute for Work & Health
IWK Health Centre

John Abbott College
Justice Institute of British Columbia

Keenan Research Centre
King's University College at Western University
Kwantlen Polytechnic University

MacEwan University (Grant MacEwan University)
McGill University
McMaster University
Memorial University of Newfoundland
Métis Nation of Ontario
Mount Royal University
Mount Saint Vincent University
Moyo Health and Community Services

Native Women's Association of Canada
North Island College
North York General Hospital
Northern Ontario School of Medicine
Nova Scotia Health Authority

OCAD University
Ontario Centre of Excellence for Child and Youth Mental Health
Ontario Institute for Cancer Research
Ontario Tech University
Ontario Tech University (University of Ontario Institute of Technology)
Ottawa Heart Institute Research Corporation
Ottawa Hospital Research Institute

Princess Margaret Cancer Centre

Québec à Chicoutimi
Québec à Montréal
Québec à Rimouski
Québec à Trois-Rivières
Queen's University

Royal Alexandra Hospital
Royal Roads University
Ryerson University

TÉLUQ
The University of Calgary
The University of Regina
Thompson Rivers University
Toronto General Research Institute
Trent University
Trillium Health Partners

Vancouver Island University

Western University
Western University (The University of Western Ontario)
Wilfrid Laurier University
Women's College Hospital

York University
Yukon University

Back to main page

Displaying 1 through 10 of 11 results (Download Results)

Show results per page

Assessing the impacts of COVID‑19 on routine school-based immunizations and investigating strategies to catch-up on missed immunization opportunities in Canada

Neudorf, Cordell (Cory) O | University of Saskatchewan | Operating Grant | $149,144

CIHR Saskatchewan 2021

See us, hear us 2.0-Mental health and well-being impacts of the COVID‑19 pandemic on children, youth, and families in Saskatchewan

Muhajarine, Nazeem | University of Saskatchewan | Operating Grant | $149,926

CIHR Saskatchewan 2021

mamawohkamatowin: working together to understand the house and COVID‑19 in a Saskatchewan First Nation Community

Kirychuk, Shelley | University of Saskatchewan | Operating Grant | $272,415

CIHR Saskatchewan 2021

Impact de la pandémie sur les familles francophones dans les Prairies canadiennes

Leis, Anne M | University of Saskatchewan | Operating Grant | $146,835

CIHR Saskatchewan 2021

Functional analyses of pathogenicity determinants of SARS-Coronavirus-2 delta variant

Victoria Ansalem, Anil Kumar | University of Saskatchewan | Project Grant | $96,270

CIHR Saskatchewan 2021

COVID-19 Variant Supplement – BLT-Lung mice for the rapid evaluation of COVID‑19 therapeutics

Lavender, Kerry J | University of Saskatchewan | Operating Grant | $50,000

CIHR Saskatchewan 2021

SARS-CoV-2 virus infection in vaccinated vulnerable populations and the potential for variant emergence

Kelvin, Alyson A | University of Saskatchewan | Operating Grant | $499,900

CIHR Saskatchewan 2021

COVID-19 Variant Supplement – Vaccine efficacy in nonhuman primates against SARS-CoV-2: protection, cross-protection and immune enhancement

Falzarano, Darryl | University of Saskatchewan | Operating Grant | $50,000

CIHR Saskatchewan 2021

COVID-19 Variant Supplement – SARS-CoV2 therapeutic discovery through genetic screens and repurposing drugs that target essential virus-host interactions.

Wilson, Joyce A | University of Saskatchewan | Operating Grant | $50,000

CIHR Saskatchewan 2021

COVID-19 Variant Supplement – Development of SARS-CoV-2 Peptide Therapeutics and Point-of-Care Salivary Diagnostics for Rapid Viral Detection

Babu, Mohan | The University of Regina | Operating Grant | $50,000

CIHR Saskatchewan 2021

The Canadian COVID‑19 Funded Research Database

Advanced Keyword Search

Provinces & Territories (12)

Institutions (175)

A

B

C

D

E

F

G

H

I

J

K

L

M

N

O

P

Q

R

S

T

U

V

W

Y

Years (4)

Funding Agencies (3)

Languages (2)

Funding Amount

Assessing the impacts of COVID‑19 on routine school-based immunizations and investigating strategies to catch-up on missed immunization opportunities in Canada

See us, hear us 2.0-Mental health and well-being impacts of the COVID‑19 pandemic on children, youth, and families in Saskatchewan

mamawohkamatowin: working together to understand the house and COVID‑19 in a Saskatchewan First Nation Community

Impact de la pandémie sur les familles francophones dans les Prairies canadiennes

Functional analyses of pathogenicity determinants of SARS-Coronavirus-2 delta variant

COVID-19 Variant Supplement – BLT-Lung mice for the rapid evaluation of COVID‑19 therapeutics

SARS-CoV-2 virus infection in vaccinated vulnerable populations and the potential for variant emergence

COVID-19 Variant Supplement – Vaccine efficacy in nonhuman primates against SARS-CoV-2: protection, cross-protection and immune enhancement

COVID-19 Variant Supplement – SARS-CoV2 therapeutic discovery through genetic screens and repurposing drugs that target essential virus-host interactions.

COVID-19 Variant Supplement – Development of SARS-CoV-2 Peptide Therapeutics and Point-of-Care Salivary Diagnostics for Rapid Viral Detection